cbdMD’s Herbal Oasis Hemp-Derived THC-Infused Social Seltzer Brand Expands its Product Offerings

CHARLOTTE, NC / ACCESS Newswire / October 22, 2025 / cbdMD, Inc. (NYSE American:YCBD), one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD products and Farm Bill-compliant Delta-9 offerings, today announced the addition of two new 10mg flavors to its Herbal Oasis […]

Is Your Business Really Protected? 7 Reasons SimpliSafe’s New Business Security System Services Are a Game-Changer for Small Businesses

MISSION, Kan., Oct. 22, 2025 (GLOBE NEWSWIRE) — (Family Features) If you run a small business, you know that security isn't just about locking the doors – it's about protecting your livelihood, your team, and your customers. But with so many options out there, how do you choose the best security system for your business

Is Your Business Really Protected? 7 Reasons SimpliSafe’s New Business Security System Services Are a Game-Changer for Small Businesses

Is Your Business Really Protected? 7 Reasons SimpliSafe's New Business Security System Services Are a Game-Changer for Small Businesses New suite of security solutions, featuring AI-powered cameras and proactive live agent monitoring, delivers peace of mind for business owners GlobeNewswire October 22, 2025 MISSION, Kan., Oct. 22, 2025 (GLOBE NEWSWIRE) — (Family Features) If you

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. – ACAD

NEW YORK CITY, NY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ:ACAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Acadia and certain of its officers

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CarMax, Inc. – KMX

NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. ("CarMax" or the "Company") (NYSE:KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CarMax and certain of its officers and/or directors

Pomerantz Law Firm Announces the Filing of a Class Action Against Fluor Corporation and Certain Officers – FLR

NEW YORK, NY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under

Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers – JSPR

NEW YORK, NY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010,

LIFEMD, INC. (NASDAQ:LFMD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds LifeMD, Inc. Investors of Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ:LFMD) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Marex Group Plc of Class Action Lawsuit And Upcoming Deadlines – MRX

NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Scroll to Top